Healthcare

AstraZeneca's COVID-19 vaccine never received emergency-use authorization in the U.S. Will the FDA approve its antibody cocktail?

Cognition Therapeutics (CGTX) has priced its IPO, and is expected to list on Oct. 8. What’s CGTX’s stock forecast, and is it a buy for investors?

Moderna submitted a request in June for emergency use authorization of its two-shot COVID-19 vaccine for children aged 12–17. The FDA hasn’t given its approval yet.

Who owns the malaria vaccine? The first vaccine against parasitic disease receives WHO approval

Those who are eligible for the Pfizer vaccine booster shot fall under specific groups deemed to be at higher risk of reinfection or server disease.

Parents and schools are eagerly awaiting COVID-19 vaccines for younger children as the Delta variant spreads. When will Pfizer's vaccine be approved for children under 12?

Investors want to know when the FDA will fully approve Moderna’s COVID-19 vaccine. FDA approval could fuel sales. Here's what investors can expect.

TransCode Therapeutics stock was trading sharply higher on Sept. 22. Why is RNAX stock going up and what’s the forecast for the stock?

Currently, SmileDirectClub is among the popular stocks on Reddit group WallStreetBets. Is SDC a good stock to buy now?

With conflicting advice about COVID-19 vaccine booster shots, when will they be available for Americans? What are the current recommendations?

The short volumes of SDC stock look high enough to trigger a squeeze. What’s SDC’s stock forecast, and how high can Reddit investors take it?

Clinical trials for COVID-19 vaccine safety and effectiveness in children under 12 are ongoing. Demand for trial participation is high, so parents might need to be patient.

GlaxoSmithKline might have settled the largest healthcare lawsuit in U.S. history, by Pfizer still holds the record for paying the largest criminal fine.

Humanigen (HGEN) stock was trading sharply lower in the premarket on Sept. 9. Why is HGEN stock falling and should you buy the dip now?

On Sept. 8, Sanofi agreed to acquire Kadmon for about $1.9 billion. What’s KDMN’s stock price forecast and is it a good buy ahead of the acquisition?

Pfizer-BioNTech vaccine became the first vaccine to be fully approved for COVID-19 by the FDA. Moderna’s vaccine is still awaiting FDA approval, but why?

SONN’s stock forecast is in focus after the company picked a new pipeline candidate. Is SONN stock a good long-term investment?

Why is SAVA stock being shorted? There has been controversy around its Alzheimer's drug research. Here's what investors can expect.

Zomedica (ZOM) stock rose almost 14 percent on Aug. 25. Why is ZOM stock rising, and what’s the forecast for the stock in 2021?

Avalon GloboCare stock has fallen from its peak. What's the forecast for AVCO in 2021? Will it go up, and is it a good penny stock to buy now?

BioNTech (BNTX) stock was trading sharply higher after getting full FDA approval for its COVID-19 vaccine. What's the forecast for the stock and how high can it go?

Clover Health stock has had a volatile run as a publicly traded company. However, after declining by nearly 39 percent in July, the stock has recouped some of the losses lately.

Axsome Therapeutics (AXSM) stock has hit a 52-week low. What's the forecast for AXSM stock and will it go back up? Here's what investors can expect.

Senseonics (SENS) is set to release its earnings in August. What's the forecast for the stock? Will the stock rise or fall? Here's what investors can expect.

BYSI stock rose 176 percent on Aug. 4. What’s BYSI’s stock forecast and how high can it reasonably go? Will it reach $100?

Infinity Pharmaceuticals (INFI) stock has experienced wild swings lately. The company disclosed the clinical trial results for its leading candidate eganelisib.

Glenmark Life Sciences has its IPO this week and is highly oversubscribed. Here's how to check your allotment application status.

Robotics company Vicarious Surgical is expected to go public sometime in the third quarter of 2021 through a merger with a SPAC.

Should you get critical illness insurance? Find out what this type of coverage is—and isn’t—and what experts say about its utility.

Clover Health (CLOV) stock has pulled back sharply from its peak. Investors want to know if now is a good time to buy the stock.

Sema4 Holdings (SMFR) and CMLF completed their merger on July 22. What's SMFR's stock forecast after the merger?

Moderna stock has tripled this year. After its price surge, investors want to know Moderna's (MRNA) stock forecast for 2025. Does it look promising?

23andMe (ME) stock has fallen 45 percent from its peaks. Many investors wonder if the biotech stock will go back up. Here's what we know.

Erasca is listing on July 16. Is the stock a good buy for investors? What’s the forecast for the clinical-stage company?

Clover Health stock is down almost 70 percent from its 52-week highs. Why is CLOV stock going down and will it go back up?

Walmart has dropped an insulin pen that's cheaper than high-price alternatives. Is Walmart's insulin pen safe? What can consumers expect?

Gene-editing stocks are rising in popularity, and Cathie Wood is also backing them. What should investors know about gene-editing stocks?

Doximity, a social network for physicians, is scheduled to go public soon. Unlike most of the recent companies that have gone public, Doximity is profitable. Should you buy Doximity IPO stock?

23andMe stock has fallen sharply from its peaks. What’s the forecast for ME, and is it the next short squeeze target for Reddit investors?

23andMe (ME) stock had a strong stock market debut through its SPAC merger with VGAC. How high can ME stock go?